I-Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3 Purity >99.0% (HPLC) Factory High Quality

Incazelo emfushane:

Igama Lekhemikhali: 3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride

I-CAS: 486460-21-3

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Impushana Emhlophe Kuya Kumphuzi Okhanyayo

I-Sitagliptin Phosphate Monohydrate emaphakathi (CAS: 654671-77-9) yokwelashwa kwesifo sikashukela sohlobo II

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali 3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride
Omqondofana I-Sitagliptin Phosphate Monohydrate Intermediate
Inombolo ye-CAS 486460-21-3
Inombolo yeCAT I-RF-PI1194
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C6H7F3N4
Isisindo samangqamuzana 192.14
Iphuzu elibilayo 266℃
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kumphuzi Okhanyayo
Ukuhlonza I-spectrum yokumuncwa kwe-UV yesampula evamile ibonisa ubukhulu & ubuningi obungamaza amaza afanayo
Ukuhlonza I-HPLC: Isikhathi sokugcina Siyafana
Ukulahlekelwa Ekumisweni <2.00%
Ukungcola Okuvamile <1.00%
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa Okumaphakathi kwe-Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-3-(Trifluoromethyl)-5,6,7,8-tetrahydro--[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride (CAS: 486460-21-3) iphakathi kwe-Sitagliptin Phosphate Monohydrate ( I-CAS: 654671-77-9) yokwelashwa kwesifo sikashukela sohlobo II.I-Sitagliptin igunyazwe yi-FDA njengesengezo ekudleni nasekuzivocavoceni ukuze kuthuthukiswe ukulawulwa kwe-glycemic ezigulini ezine-T2DM, kungaba njenge-monotherapy, noma ihlanganiswe ne-metformin noma i-peroxisome proliferatoractivated receptor-γ agonist (ngokwesibonelo, i-thiazolidinediones) lapho i-ejenti eyodwa. ayinikezi ukulawulwa okwanele kwe-glycemic.

Bhala umyalezo wakho lapha futhi usithumelele wona